Humana Shares Rise on Improved Medicare Advantage Star Ratings
Humana's stock rose nearly 12% after the company announced that 95% of its Medicare Advantage members will be enrolled in plans rated four stars or higher for 2027. The improvement is expected to enhance Humana’s competitive position within the Medicare Advantage market, which has become increasingly important as more seniors opt for private health insurance options under Medicare. The stock closed at $431.87 on Friday after gaining $44.75 during the session. This performance reflects investor optimism about the company's ability to maintain and grow its share of this lucrative segment, which is critical in a highly regulated healthcare industry where star ratings significantly influence enrollment decisions. The announcement highlights Humana’s ongoing efforts to improve quality metrics across its plans, aligning with broader trends toward value-based care models within Medicare Advantage.
Tickers: $HUM
Topics: Healthcare Medicare Advantage